Loading
The Radiance 330® Proton Therapy System is a compact, modular and an economically viable proton therapy system, allowing health care providers to develop single or multiple-room capability within or adjacent to an existing radiation oncology department, making proton therapy an extension of the radiation oncology.
The Radiance 330’s modular designed treatment system utilizes an advanced pencil beam scanning technology and a compact synchrotron particle accelerator, which delivers a clinical treatment energy range from 70 MeV to 250 MeV with a capacity of up to 330 MeV for future deployment of proton imaging.
The Radiance 330 has received U.S. FDA 510(k) clearance and has an approved phased commissioning and regulatory plan from the Australian Therapeutic Goods Administration (TGA). Offering significant economic, technical, and clinical advantages, it reduces capital and operational costs, enhances beam accuracy and precision, and minimizes the number of treatments required. This translates to less collateral tissue damage, lower radiation exposure, and reduced overall medical expenses—benefiting healthcare providers, payers, and patients alike.
The Radiance 330 has been treating patients in the US.
One Fixed Beam and One Gantry Room Configuration
